Item 7.01 Regulation FD Disclosure.

Beam Therapeutics Inc. (the "Company") will be conducting meetings with participants attending the 39th Annual J.P. Morgan Healthcare Conference (the "Conference"). The slides to be presented by the Company at the Conference are furnished with this report as Exhibit 99.1, which is incorporated herein by reference.

The information in this Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing by the Company, under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filling.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit No.   Description

99.1            Beam Therapeutics Inc. Presentation at the 39th Annual J.P. Morgan
              Healthcare Conference

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses